CHF-6550

N/A

Report date: 2024/04/12 16:24:39

Base Information

Drug NameCHF-6550
Drug Alias NameCHF-6550CHF6550
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor antagonistsBeta-2 adrenergic receptor agonists
TargetsMuscarinic acetylcholine receptorBeta-2 adrenergic receptor
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAptuit (Verona) SrlChiesi Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesAptuit (Verona) SrlChiesi Pharmaceuticals Llc
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A